Related Experiment Video
Updated: Feb 7, 2026

A Sensitive Method to Quantify Senescent Cancer Cells
Published on: August 2, 2013
Targeting of the C-Jun/BCL-XL/P21 Axis Accelerates the Switch from Senescence to Apoptosis Upon ROC1 Knockdown in
Ping Chen1,2, Xiaoting Luo1, Zhihui Che1
1Department of Digestive Diseases of Huashan Hospital, Fudan University, Shanghai, China.
Background/Aims:
Regulator of cullins-1 (ROC1) is a pivotal component of cullin-RING E3 ubiquitin ligases, which help to regulate distinct cellular processes by governing the degradation of various substrates. Because the role of ROC1 in gastric cancer is largely uncharacterized, we investigated the relationship between ROC1 expression and the prognosis of gastric cancer patients and explored the biological function of ROC1 and its underlying mechanisms in gastric cancer.
Methods:
Kaplan-Meier and multivariate Cox regression analyses were used to evaluate the correlation between the carcinogenesis of gastric cancer and ROC1. SA-β-gal staining and the senescence-associated secretory phenotype (SASP) were used to assess ROC1 silencing-induced cellular senescence. A xenograft zebrafish model was used to evaluate the effects of BCL-XL and ROC1 co-silencing on tumor formation in vivo.
Results:
High ROC1 expression was correlated with poor prognosis and a low 5-year survival rate of gastric cancer patients. ROC1 depletion significantly inhibited the growth of gastric cancer cells by sequentially inducing p21-mediated cellular senescence and mitochondrial-dependent apoptosis. Functional studies revealed successive upregulation of c-Jun, BCL-XL, and p21 upon ROC1 knockdown. BCL-XL suppression via RNA interference or a BH3 mimetic (ABT-737 or ABT-263) efficiently enhanced the anti-tumor effects of ROC1 knockdown. Equally as important, BCL-XL silencing strengthened ROC1 knockdown-induced apoptosis by blocking p21-mediated senescence.
Conclusions:
The c-Jun/BCL-XL/p21 axis promotes senescence to resist ROC1 knockdown-induced apoptosis in gastric cancer cells. Targeted inactivation of BCL-XL could sensitize gastric cancer cells to ROC1 knockdown in clinical practice.
Insights
Regulator of cullins-1 (ROC1) high expression correlates with poor gastric cancer prognosis. Targeting BCL-XL enhances ROC1 knockdown
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Regulator of cullins-1 (ROC1) is a key component of E3 ubiquitin ligases involved in substrate degradation.
- The role of ROC1 in gastric cancer pathogenesis remains largely uncharacterized.
- Investigating ROC1's function and prognostic significance in gastric cancer is crucial.
Purpose of the Study:
- To determine the relationship between ROC1 expression and gastric cancer patient prognosis.
- To explore the biological functions of ROC1 in gastric cancer.
- To elucidate the underlying molecular mechanisms of ROC1 in gastric cancer progression.
Main Methods:
- Kaplan-Meier and multivariate Cox regression analyses for ROC1 correlation with gastric cancer.
- SA-β-gal staining and SASP assessment for ROC1 silencing-induced cellular senescence.
- Xenograft zebrafish models to evaluate co-silencing effects of BCL-XL and ROC1 on tumor formation.
Main Results:
- High ROC1 expression is linked to poor prognosis and reduced 5-year survival in gastric cancer patients.
- ROC1 depletion inhibits gastric cancer cell growth via p21-mediated senescence and apoptosis.
- The c-Jun/BCL-XL/p21 axis promotes senescence, resisting apoptosis upon ROC1 knockdown.
Conclusions:
- The c-Jun/BCL-XL/p21 pathway mediates senescence as a resistance mechanism to ROC1 knockdown-induced apoptosis in gastric cancer.
- Targeting BCL-XL can sensitize gastric cancer cells to ROC1 knockdown, offering potential clinical strategies.
More Related Videos
Related Concept Videos
Replicative Cell Senescence
Targeted Cancer Therapies
There are several types of targeted therapies against...
Apoptosis
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Hypothalamic-Pituitary Axis
Accelerators
The effectiveness of calcium chloride can...

